MDxHealth MDxHealth Files for IPO of American Depository Shares The company, headquartered in Belgium and the US, hasn't yet made public the number of ADSs it plans to offer, or the timing and price for the offering. MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound The firm saw volume growth of 4 percent for its ConfirmMDx prostate cancer test and 9 percent for its SelectMDx test. Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions. MDxHealth 2020 Revenues Up 57 Percent Billable test volume for the company's ConfirmMDx and SelectMDx prostate cancer test fell year over year, but rose sequentially from the third quarter. Oppenheimer Initiates Coverage of MDxHealth at Outperform The investment bank cited its expectation for a positive coverage decision from Medicare for the company's SelectMDx prostate cancer test, among other reasons. Oct 21, 2020 MDxHealth Q3 2020 Revenues Drop 6 Percent Aug 26, 2020 MDxHealth H1 2020 Revenues Down 9 Percent on Declining Test Volumes Apr 27, 2020 MDxHealth Receives €12.7M Investment From MVM Partners Apr 9, 2020 MDxHealth Q1 Revenues Up 24 Percent; Company Suspends 2020 Guidance Feb 26, 2020 MDxHealth 2019 Revenues Fall 58 Percent Nov 11, 2019 MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period Oct 4, 2019 Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More Sep 26, 2019 MDxHealth Plans Private Placement, Signs $9.9M Loan Agreement Aug 29, 2019 MDxHealth H1 2019 Revenues Fall 37 Percent Aug 22, 2019 Local Coverage Determinations Roundup: MDxHealth, Myriad, AltheaDx, Natera, and More Apr 24, 2019 MDxHealth Q1 Revenues Drop 51 Percent Feb 28, 2019 MDxHealth Posts Flat Year-Over-Year Revenues for 2018 Feb 14, 2019 MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay Jan 14, 2019 MDxHealth Preliminary 2018 Revenues Drop Nearly 1 Percent Nov 26, 2018 MDxHealth Prostate Cancer Test Gains New York State Approval Oct 23, 2018 MDxHealth's Product Sales Jump but Lower Royalty Revenue Hits Top-Line Results Aug 30, 2018 MDxHealth H1 Revenues Fall 29 Percent Aug 15, 2018 MDxHealth Hopes to Build Lead in Prostate Risk Testing With Utility Evidence for SelectMDx Premium Jul 23, 2018 Palmetto Issues Positive Final LCD for MDxHealth Prostate Cancer Test Jun 6, 2018 MDxHealth Licenses Prognostic Prostate Cancer Biomarker From Philips Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.